Share

Unassisted and assisted HIV self-testing among female sex workers, men who have sex with men, and priority populations before and during COVID-19 and political conflict in Mali

Title
Presenter
Authors
Institutions

BACKGROUND: The USAID-funded EpiC Mali project supports the provision of HIV prevention and treatment services to key populations (KPs) (female sex workers (FSW) and men who have sex with men (MSM) and priority populations (PPs) (non-KPs at high risk). In collaboration with the UNITAID-funded ATLAS project, KP peer navigators create demand at hot spots, offer HIV self-testing (HIVST) following risk assessment and as part of index testing, and navigate individuals to confirmatory testing and treatment sites. In March 2020, Mali government issued a one-month curfew followed by other restrictions to control COVID-19, and political unrest, until September 2020.
DESCRIPTION: In October 2019, EpiC Mali began distributing HIVST kits to hard-to-reach KPs and PPs for unassisted use to increase case detection. During COVID-19 restrictions and political conflict, HIVST was further expanded to continue reaching high-risk KPs and PPs, in compliance with COVID-19 prevention measures, through contactless distribution, but now with increased provider assistance, and phone-based results follow-up.
LESSONS LEARNED: From October 2019 to September 2020, 11,579 HIVST kits were distributed. HIVST returns increased from 15% before COVID-19/political conflict to 72% post COVID-19/political conflict, particularly among KPs, although baseline return rate for PPs was four times higher than for KPs. The overall reactivity rate remained constant over time (KPs: 6%; PPs: 5%), but it decreased among MSM and increased among PPs. The contribution of HIVST to total HIV case finding increased from 4% to 13% (p< .01; OR 3.24; CI 2.36'4.45) (Table 1).

Table 1. HIVST cascade, October 1, 2019'September 30, 2020
PopulationOctober 2019'March 2020 (Pre-COVID-19/Political Conflict)April'September 2020 (during COVID-19/Political Conflict)October 2019'September 2020 (Complete Time Period)
HIVST kits distributedHIVST returnedHIVST returned (%)HIVST reactiveHIVST reactive (%)HIVST reactive and confirmed positiveTotal HIV positive (including reactive HIVST confirmed positive)Reactive HIVST confirmed positive contribution to total HIV positiveHIVST distributedHIVST returnedHIVST returned (%)HIVST reactiveHIVST reactive (%)HIVST reactive and confirmed positiveTotal HIV positive (including reactive HIVST confirmed positive)Reactive HIVST confirmed positive contribution to total HIV positive (%)HIVST distributedHIVST returnedHIVST returned (%)HIVST reactiveHIVST reactive (%)HIVST reactive and confirmed positiveTotal HIV positive (including reactive HIVST confirmed positive)Reactive HIVST confirmed positive contribution to total HIV positive (%)
FSWs5,03468714%396%396736%4,5503,32873%1545%1151,04211%9,5844,01542%1935%1541,7159%
MSM84711614%109%101517%93962767%396%3720218%1,78674342%496%4735313%
PP1308162%22%22141%795772%2239%223037%20913866%2417%245174.6%
Total6,01188415%516%511,2654%5,5684,01272%2155%1741,69313%11,5794,89642%2665%2252,9588%

CONCLUSIONS: COVID-19 and political conflict provided the impetus to shift HIVST from unassisted to assisted, resulting in a fivefold increase in return rates and a continued high reactivity rate. Decreased reactivity among MSM could be due to less targeted HIVST kit distribution, while high baseline return rate and high reactivity rate at follow-up among PPs requires further analysis. The increased contribution to overall case finding highlights potential of HIVST, particularly when emergencies arise.